A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve

AIMS: The mechanistic basis of the symptoms and signs of myocardial ischaemia in patients without obstructive coronary artery disease (CAD) and evidence of coronary microvascular dysfunction (CMD) is unclear. The aim of this study was to mechanistically test short-term late sodium current inhibition...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur Heart J
Autori principali: Bairey Merz, C. Noel, Handberg, Eileen M., Shufelt, Chrisandra L., Mehta, Puja K., Minissian, Margo B., Wei, Janet, Thomson, Louise E.J., Berman, Daniel S., Shaw, Leslee J., Petersen, John W., Brown, Garrett H., Anderson, R. David, Shuster, Jonathan J., Cook-Wiens, Galen, Rogatko, André, Pepine, Carl J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2016
Soggetti:
Aha Fasttrack
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872284/
https://ncbi.nlm.nih.gov/pubmed/26614823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv647
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi